Back to Top Skip to main content Skip to sub-navigation

San Antonio volunteers sought for Warp Speed vaccine trials

Woman typing on laptop Marcy Edwards, a Military Health System beneficiary, signs up for Operation Warp Speed, Nov. 2, 2020. Operation Warp Speed is a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (Photo courtesy of Jason Edwards.)

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | Vaccine Trials | COVID-19 Vaccine Toolkit

Two San Antonio area Military Health System facilities are seeking volunteers from among the military beneficiary population to participate in a COVID-19 vaccine trial.

The trial is part of Operation Warp Speed, a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

The Brooke Army Medical Center aboard Joint Base San Antonio-Fort Sam Houston, and the Wilford Hall Ambulatory Surgical Center at Joint Base San Antonio-Lackland are among the five Department of Defense locations taking part in the Phase III trial to evaluate the vaccine under development by AstraZeneca.

The other sites are Naval Medical Center San Diego in California, Walter Reed National Military Medical Center in Bethesda, Maryland, and Fort Belvoir Community Hospital in Virginia.

"The San Antonio Military Health System is proud to answer the call to help serve the needs of our nation in these unprecedented times," said Air Force Maj. Gen. John DeGoes, SAMHS market director and 59th Medical Wing commander. "We are proud to be selected as a partner in the effort to accelerate development of COVID-19 vaccines."

Army Brig. Gen. Shan Bagby, BAMC commanding general added, “We are honored to be among those sites selected in support of this whole-of government effort to ensure safe, effective medical products are provided at a critical time to the American people. SAMHS has the existing research infrastructure and experience to make a significant contribution to this important effort.”

The AstraZeneca vaccine trial is one of many national trials being conducted through Operation Warp Speed, and the first to encompass the DOD. With more than 80 sites nationwide, the trial has an overall target enrollment of 30,000 participants. Military sites are looking to draw 3,000 of those volunteers, according to a DOD release.

DOD sites are open on a voluntary basis to Military Health System beneficiaries – active duty, retirees and family members 18 years of age and older.

Beneficiaries can sign up for consideration by reaching out to either site:

Wilford Hall Ambulatory Surgical Center (Site Code: WHASC)
Recruitment Phone Number: 253-341-6170
Email: covidwhasc@genevausa.org 

Brooke Army Medical Center (Site Code: BAMC)
Recruitment Phone Number: 253-924-9458
Email: covidbamc@genevausa.org 

Alternatively, volunteers can also visit www.CoronavirusPreventionNetwork.org, click on “Volunteer Now” and complete the survey. When requested, volunteers should enter the appropriate site code, depending on their preference and geographic location.

Once the survey is completed, local study site coordinators will screen volunteers and contact those participants in their area who may be a good match for the study. Volunteers should consult with the study coordinator if they are scheduled to move, change their duty station or deploy within 12 months of beginning participation.

According to the DOD release, the study is looking for people who are at an increased risk of SARS-CoV-2 infection, which may include:

  • Working in an essential job, such as healthcare professions, emergency response personnel, grocery workers, meat-packing plants, restaurant staff, public transit, etc.
  • Living in densely populated residential environments
  • Living or working in congregated living facilities, such as nursing homes
  • A member of a community that has been hardest hit by this pandemic, such as older people, individuals with underlying health conditions, and racial/ethnic groups such as African Americans, Latino, and Native American populations.

Volunteers selected will be enrolled into the study. Once the local sites are active, participants will be called in to receive two doses of the vaccine or placebo about a month apart.

Along with scheduled visits, participants will be asked to come in if they have symptoms throughout the year to be tested for COVID-19. Study participants will be followed for two years to determine the vaccine’s efficacy, while being compensated for their participation.

You also may be interested in...

COVID-19: Know what the terms mean

Article
3/10/2020
Soldiers stationed on U.S. Army Garrison Casey conduct pre-screening processes on individuals awaiting entry to the base, USAG-Casey, Dongducheon, Republic of Korea, Feb. 26, 2020. Additional screening measures of a verbal questionnaire and temperature check are in response to the heighted awareness of Coronavirus (COVID-19) following a surge in cases throughout the Republic of Korea and are meant to help control the spread of COVID-19 and to protect the force. (U.S. Army photo by Sgt. Amber I. Smith)

Learning the language can help you stay safe

Recommended Content:

Coronavirus | Public Health | Combat Support | Coronavirus

Coronavirus: What you need to know

Article
3/6/2020
A Guardsmen with the 341st Military Intelligence Battalion conducts translation work on a safety message regarding the best practices for avoiding the novel coronavirus for the Washington Department of Health on Feb. 9, 2020 at the Information Operations Readiness Center, Joint Base Lewis-McChord, Wash. (Courtesy Photo)

Although news stories and images contain many reports of people wearing surgical masks to ward off the virus, that's not recommended

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

DoD makes plans to combat Coronavirus

Article
3/4/2020
Defense Secretary Dr. Mark T. Esper and Army Gen. Mark A. Milley, chairman of the Joint Chiefs of Staff, speak to reporters at the Pentagon, March 2, 2020. (DoD photo Lisa Ferdinando)

The number one priority remains to protect our forces and their families

Recommended Content:

Coronavirus | Public Health | Combat Support | Coronavirus

MHS prepared to support interagency coronavirus response

Article
2/6/2020
Airmen assist one another in donning their personal protective equipment, while on-board an Air Force C-17 Globemaster III during transportation isolation system training at Joint Base Charleston, South Carolina. Engineered and implemented after the Ebola virus outbreak in 2014, the TIS is an enclosure the Department of Defense can use to safely transport patients with diseases like novel coronavirus. (U.S. Air Force photo by Senior Airman Cody R. Miller)

From R&D to force health protection, MHS protects DoD personnel and families

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

DoD releases guidance to protect forces from novel coronavirus

Article
1/31/2020
The novel coronavirus is a variant of other coronaviruses, such as this colorized transmission electron micrograph of Middle East respiratory syndrome (MERS) virus particles (blue) found near the periphery of an infected VERO E6 cell (yellow). Image captured and color-enhanced at the NIAID Integrated Research Facility in Fort Detrick, Maryland. (Photo by NIAID)

Basic infection controls offer best defense against illness

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

Coronavirus: What providers, patients should know

Article
1/24/2020
Many forms of coronavirus exist among both humans and animals, but this new strain’s has caused alarm. (CDC graphic)

What to do now that virus has appeared in U.S.

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

MHS GENESIS Patient Portal Fact Sheet

Fact Sheet
7/30/2019

This fact sheet describes the MHS GENESIS Patient Portal.

Recommended Content:

COVID-19 Vaccine Toolkit | MHS GENESIS Toolkit
<< < ... 41 42 43 > >> 
Showing results 631 - 637 Page 43 of 43

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.